Ryvu Therapeutics S.A. (FRA:9Y4)

Germany · Delayed Price · Currency is EUR

5.93

+0.05 (0.85%)

Last updated: Feb 23, 2026, 8:04 AM CET

Revenue by Segment

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Innovation	101.96M	67.30M	68.44M	35.41M	36.95M
Innovation Growth	51.51%	-1.67%	93.25%	-4.16%	9.58%
Total	101.96M	67.30M	68.44M	35.41M	36.95M
Total Growth	51.51%	-1.67%	93.25%	-4.16%	9.58%

Revenue by Geography

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Poland	56.00K	38.00K	106.00K	156.00K	272.49K
Poland Growth	47.37%	-64.15%	-32.05%	-42.75%	20860.46%
EU Members	69.33M	41.66M	24.62M	11.03M	15.38M
EU Members Growth	66.40%	69.25%	123.15%	-28.27%	306.80%
Other Countries	8.59M	5.16M	14.23M	-	-
Other Countries Growth	66.38%	-63.73%	-	-	-
Total	77.97M	46.86M	38.95M	11.19M	15.65M
Total Growth	66.38%	20.32%	248.15%	-28.52%	312.04%

Source: S&P Global Market Intelligence.